While p53-dependent apoptosis is triggered by combination of methyltransferase inhibitor decitabine (DAC) and histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) in leukemic cell line CML-T1, reactive oxygen species (ROS) generation as well as survivin and Bcl-2 deregulation participated in DAC + SAHA-induced apoptosis in p53-deficient HL-60 cell line. Moreover, decrease of survivin expression level is accompanied by its delocalization from centromere-related position in mitotic cells suggesting that both antiapoptotic and cell cycle regulation roles of survivin are affected by DAC + SAHA action. Addition of subtoxic concentration of all-trans-retinoic acid (ATRA) increases the efficiency of DAC + SAHA combination on viability, apoptosis induction, and ROS generation in HL-60 cells but has no effect in CML-T1 cell line. Peripheral blood lymphocytes from healthy donors showed no damage induced by DAC + SAHA + ATRA combination. Therefore, combination of ATRA with DAC and SAHA represents promising tool for therapy of leukemic disease with nonfunctional p53 signalization.

Institute of Hematology and Blood Transfusion U Nemocnice 1 128 20 Prague 2 Czech Republic

See more in PubMed

Joeckel TE, Lübbert M. Clinical results with the DNA hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update. Seminars in Hematology. 2012;49(4):330–341. PubMed

Lübbert M, Rüter BH, Claus R, et al. A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy. Haematologica. 2012;97(3):393–401. PubMed PMC

Meng CF, Su B, Li W. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells. Molecular Medicine Reports. 2011;4(6):1273–1278. PubMed

Steele N, Finn P, Brown R, Plumb JA. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo . British Journal of Cancer. 2009;100(5):758–763. PubMed PMC

Brodská B, Holoubek A, Otevřelová P, Kuželová K. Combined treatment with low concentrations of decitabine and SAHA causes cell death in leukemic cell lines but not in normal peripheral blood lymphocytes. BioMed Research International. 2013;2013:11 pages.659254 PubMed PMC

Ganesan A, Nolan L, Crabb SJ, Packham G. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. Current Cancer Drug Targets. 2009;9(8):963–981. PubMed

Eto M, Kodama S, Uemura N, Suzuki M. Antibody responses to survivin and their clinical significance in patients with head and neck cancer. Head and Neck. 2007;29(12):1128–1135. PubMed

Raj D, Liu T, Samadashwily G, Li F, Grossman D. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis. 2008;29(1):194–201. PubMed PMC

Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochemical Journal. 1999;344(2):305–311. PubMed PMC

Honda R, Körner R, Nigg EA. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Molecular Biology of the Cell. 2003;14(8):3325–3341. PubMed PMC

Chu Y, Yao PY, Wang W, et al. Aurora B kinase activation requires survivin priming phosphorylation by PLK1. Journal of Molecular Cell Biology. 2011;3(4):260–267. PubMed PMC

Fukuda S, Mantel CR, Pelus LM. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood. 2004;103(1):120–127. PubMed

Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396(6711):580–584. PubMed

Kaminskyyy VO, Surovay OV, Vaculova A, Zhivotovsky B. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Carcinogenesis. 2011;32(10):1450–1458. PubMed

Yang L, Xu RR, Song GQ, et al. Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008;16(4):819–823. PubMed

Gao Q, Yang S, Kang M-Q. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer. Molecular Medicine Reports. 2012;5(6):1409–1414. PubMed

Zhao X, Ogunwobi OO, Liu C. Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells. PLoS ONE. 2011;6(8)e21980 PubMed PMC

Vrana JA, Decker RH, Johnson CR, et al. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-xL, c-Jun, and p21CIP1, but independent of p53. Oncogene. 1999;18(50):7016–7025. PubMed

Peart MJ, Tainton KM, Ruefli AA, et al. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. Cancer Research. 2003;63(15):4460–4471. PubMed

Mitsiades N, Mitsiades CS, Richardson PG, et al. Molecular sequelae of histone deacetylase inhibition in human malignant B cells. Blood. 2003;101(10):4055–4062. PubMed

He LZ, Tolentino T, Grayson P, et al. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. Journal of Clinical Investigation. 2001;108(9):1321–1330. PubMed PMC

Pisani F, del Poeta G, Aronica G, Venditti A, Caravita T, Amadori S. In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts. Annals of Hematology. 1997;75(4):145–147. PubMed

Bradbury DA, Aldington S, Zhu Y-M, Russell NH. Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression. British Journal of Haematology. 1996;94(4):671–675. PubMed

Mathieu J, Giraudier S, Lanotte M, Besançon F. Retinoid-induced activation of NF-κB in APL cells is not essential for granulocytic differentiation, but prolongs the life span of mature cells. Oncogene. 2005;24(48):7145–7155. PubMed

Zhang H, Rosdahl I. Expression profiles of p53, p21, bax and bcl-2 proteins in all-trans-retinoic acid treated primary and metastatic melanoma cells. International Journal of Oncology. 2004;25(2):303–308. PubMed

Wang CY, Yang TT, Chen CL, Lin WC, Lin CF. Reactive oxygen species-regulated glycogen synthase kinase-3beta activation contributes to all-trans retinoic acid-induced apoptosis in granulocyte-differentiated HL-60 cells. Biochemical Pharmacology. 2014;88:86–94. PubMed

Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood. 2001;97(9):2784–2790. PubMed

Amin HM, Saeed S, Alkan S. Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17) The British Journal of Haematology. 2001;115(2):287–297. PubMed

Dhandapani L, Yue P, Ramalingam SS, Khuri FR, Sun SY. Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression. Cancer Research. 2011;71(15):5245–5254. PubMed PMC

Chen M, Huang C, Hsu S, et al. Retinoic acid induces apoptosis of prostate cancer DU145 cells through Cdk5 overactivation. Evidence-based Complementary and Alternative Medicine. 2012;2012:11 pages.580736 PubMed PMC

James SY, Williams MA, Newland AC, Colston KW. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. General Pharmacology. 1999;32(1):143–154. PubMed

Bruserud O, Gjertsen BT, Huang T-S. Induction of differentiation and apoptosis—a possible strategy in the treatment of adult acute myelogenous leukemia. The Oncologist. 2000;5(6):454–462. PubMed

Otake Y, Sengupta TK, Bandyopadhyay S, Spicer EK, Fernandes DJ. Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA. Molecular Pharmacology. 2005;67(1):319–326. PubMed

Blagitko-Dorfs N, Jiang Y, Duque-Afonso J, et al. Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat. PLoS ONE. 2013;8(10)e75258 PubMed PMC

Kalousek I, Brodska B, Otevrelova P, Röselova P. Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes. Anti-Cancer Drugs. 2007;18(7):763–772. PubMed

Nabilsi NH, Broaddus RR, Loose DS. DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009;28(19):2046–2050. PubMed

Sun PC, Tzao C, Chen BH, Liu CW, Yu CP, Jin JS. Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells. Journal of Biomedical Science. 2010;17(1, article 76) PubMed PMC

Melucci E, Cosimelli M, Carpanese L, et al. Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres. Journal of Experimental and Clinical Cancer Research. 2013;32(1, article 13) PubMed PMC

Kindt N, Menzebach A, van de Wouwer M, Betz I, de Vriese A, Conway EM. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. The FASEB Journal. 2008;22(2):510–521. PubMed

Nawrocki ST, Carew JS, Douglas L, Cleveland JL, Humphreys R, Houghton JA. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. Cancer Research. 2007;67(14):6987–6994. PubMed

Luo P, Lin M, Lin M, Chen Y, Yang B, He Q. Function of retinoid acid receptor α and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis. Leukemia and Lymphoma. 2009;50(7):1183–1189. PubMed

Yu Z, Li W, Lu Q, et al. p21 is required for atRA-mediated growth inhibition of MEPM cells, which involves RAR. Journal of Cellular Biochemistry. 2008;104(6):2185–2192. PubMed

Park SH, Lim JS, Jang KL. All-trans retinoic acid induces cellular senescence via upregulation of p16, p21, and p27. Cancer Letters. 2011;310(2):232–239. PubMed

De los Santos M, Zambrano A, Aranda A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Molecular Cancer Therapeutics. 2007;6(4):1425–1432. PubMed

Han S, Fukazawa T, Yamatsuji T, et al. Anti-tumor effect in human lung cancer by a combination treatment of novel histone deacetylase inhibitors: SL142 or SL325 and retinoic acids. PLoS ONE. 2010;5(11)e13834 PubMed PMC

Kiningham KK, Cardozo Z, Cook C, et al. All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-κB. Free Radical Biology and Medicine. 2008;44(8):1610–1616. PubMed PMC

Seo S, Jin H, Lee H, et al. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells. Molecular Pharmacology. 2008;73(3):1005–1012. PubMed

Ding Q, Jin T, Wang Z, Chen Y. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor γ . Journal of Leukocyte Biology. 2007;81(6):1568–1576. PubMed

Kuzelova K, Grebenova D, Brodska B. Dose-dependent effects of the caspase inhibitor Q-VD-OPh on different apoptosis-related processes. Journal of Cellular Biochemistry. 2011;112:3334–3342. PubMed

Tse AK, Cao HH, Cheng CY, et al. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin. Journal of Investigative Dermatology. 2014;134:1397–1407. PubMed

Arbab IA, Looi CY, Abdul AB, et al. Dentatin induces apoptosis in prostate cancer cells via Bcl-2, Bcl-xL, Survivin downregulation, caspase-9, -3/7 activation, and NF-κB inhibition. Evidence-Based Complementary and Alternative Medicine. 2012;2012:15 pages.856029 PubMed PMC

Hagenbuchner J, Ausserlechner MJ. Mitochondria and FOXO3: breath or die. Frontiers in Physiology. 2013;4, article 147 PubMed PMC

Human Ovarian Granulosa Cells Isolated during an IVF Procedure Exhibit Differential Expression of Genes Regulating Cell Division and Mitotic Spindle Formation